Literature DB >> 3145162

Circulating heavy IgM in IgM nephropathy.

S O Disciullo1, J G Abuelo, K Moalli, J C Pezzullo.   

Abstract

IgM nephropathy (IgMN) causes nephrotic syndrome and is characterized by IgM mesangial deposits. It is speculated that these deposits are derived from circulating IgM aggregates or immune complexes, either of which would have a molecular weight heavier than that of normal IgM. To test this hypothesis the sera of 11 patients with IgMN, five patients with nephrotic syndrome of other etiologies, and 13 normal controls were analysed for such heavy IgM. The serum samples were passed over a Biogel A5M molecular sieve column and the fractions were tested for IgM concentration by enzyme linked immunosorbent assay (ELISA). The column effluent from the void volume to the IgM peak was divided into four equal regions, and the average IgM concentrations in each region were compared. The IgMN group had significantly higher IgM concentrations than normal controls in the heaviest region (0.81 +/- 0.84 vs. 0.32 +/- 0.17 micrograms/ml; P = 0.01) and in the lightest region (95.8 +/- 59.5 vs. 46.3 +/- 41.2 micrograms/ml; P = 0.02). Although the IgMN group appeared to have about double the IgM levels of the nephrotic control group in all four regions, this was only significant in the lightest (19S) region. In serum samples from two IgMN patient methods known to break antigen antibody bonds eliminated the heavy IgM; in one case we used gel filtration in potassium thiocyanate and in another ultracentrifugation at pH 2.8. In addition, the heavy IgM in this second patient exhibited complement fixation activity in a sandwich ELISA for IgM-C3 complexes. We conclude that IgMN patients have circulating heavy IgM, which by preliminary studies probably consists of complement fixing IgM immune complexes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145162      PMCID: PMC1541770     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Detection and characterization of circulating immune complexes by ultracentrifugation. Technical aspects.

Authors:  J Benveniste; C Bruneau
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

2.  The influence of phagocyte function on glomerular localization of aggregated IgM in rats.

Authors:  A Kijlstra; A Van Der Lelij; W Knutson; G J Fleuren; L A Vanes
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

3.  Immune complex assays: the first ten years.

Authors:  V Agnello
Journal:  Ann Intern Med       Date:  1981-02       Impact factor: 25.391

4.  Immunopathologic study of minimal change glomerular disease with mesangial IgM deposits.

Authors:  T Cavallo; M P Johnson
Journal:  Nephron       Date:  1981       Impact factor: 2.847

5.  The glomerular mesangium. II. Studies of macromolecular uptake in nephrotoxic nephritis in rats.

Authors:  S M Mauer; A J Fish; N K Day; A F Michael
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

6.  Mesangial proliferative glomerulonephritis.

Authors:  H K Bhasin; J G Abuelo; R Nayak; A R Esparza
Journal:  Lab Invest       Date:  1978-07       Impact factor: 5.662

7.  Impaired mesangial clearance of macromolecules in rats with chronic mesangial ferritin-antiferritin immune complex deposition.

Authors:  W F Keane; L Raij
Journal:  Lab Invest       Date:  1980-12       Impact factor: 5.662

8.  Studies of circulating immune complexes and lymphocyte subpopulations in childhood IgM mesangial nephropathy.

Authors:  C Y Lin; C M Chu
Journal:  Nephron       Date:  1986       Impact factor: 2.847

9.  Glomerular permeability to endogenous proteins in the rat: effects of acute hypertension.

Authors:  G Olivetti; K Kithier; F Giacomelli; J Wiener
Journal:  Lab Invest       Date:  1981-02       Impact factor: 5.662

10.  C3b binding immune complexes and immunoconglutinins in human sera. Detection by enzyme-linked immunosorbent assay (ELISA).

Authors:  A Hautanen; E Linder
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

View more
  7 in total

1.  IgM nephropathy in India: a single centre experience.

Authors:  Aruna V Vanikar; Kamal V Kanodia; Rashmi D Patel; Kamlesh S Suthar; Himanshu V Patel; Manoj R Gumber; Hargovind L Trivedi
Journal:  Indian J Pediatr       Date:  2012-08       Impact factor: 1.967

2.  Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.

Authors:  Yi-Miao Zhang; Qiu-Hua Gu; Jing Huang; Zhen Qu; Xin Wang; Li-Qiang Meng; Fang Wang; Gang Liu; Zhao Cui; Ming-Hui Zhao
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

Review 3.  IgM nephropathy; can we still ignore it.

Authors:  Aruna Vanikar
Journal:  J Nephropathol       Date:  2013-04-01

4.  A case report of immunoglobulin M nephropathy manifesting as crescentic glomerulonephritis and nephrotic syndrome in an adult.

Authors:  Kyoung Sook Park; Ea Wha Kang; Jeong Hae Kie
Journal:  BMC Nephrol       Date:  2019-08-27       Impact factor: 2.388

5.  The natural history of immunoglobulin M nephropathy in adults.

Authors:  Thomas M Connor; Valeria Aiello; Megan Griffith; Thomas Cairns; Candice A Roufosse; H Terence Cook; Charles D Pusey
Journal:  Nephrol Dial Transplant       Date:  2017-05-01       Impact factor: 5.992

6.  IgM nephropathy revisited.

Authors:  Muhammed Mubarak; Javed I Kazi
Journal:  Nephrourol Mon       Date:  2012-09-24

7.  Development of Immunoglobulin M Nephropathy in a Pregnant Woman.

Authors:  Koray Uludag; Yesim Celik; Nuray Yildirimer; Fatos Tekelioglu; Ali Ihsan Gunal
Journal:  Cureus       Date:  2021-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.